{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:04:53Z","timestamp":1784279093969,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81560390"],"award-info":[{"award-number":["81560390"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Basic Research Project of Science and Technology Department of Guizhou Province","award":["ZK [2024] General 136"],"award-info":[{"award-number":["ZK [2024] General 136"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05569-z","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T09:56:11Z","timestamp":1779357371000},"page":"2965-2980","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["N-glycosylation of ERLIN2 promotes hepatocellular carcinoma progression by enhancing CCNB1 stability"],"prefix":"10.1007","volume":"481","author":[{"given":"Sijie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daquan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"issue":"3","key":"5569_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"5569_CR2","doi-asserted-by":"publisher","first-page":"189290","DOI":"10.1016\/j.bbcan.2025.189290","volume":"1880","author":"CV Schneider","year":"2025","unstructured":"Schneider CV, Decraecker M, Beaufr\u00e8re A, Payanc\u00e9 A, Coilly A, Schneider KM, Bioulac P, Blanc JF, Le Bail B, Amintas S, Bouchecareilh M (2025) Alpha-1 antitrypsin deficiency and primary liver cancers. Biochim Biophys Acta Rev Cancer 1880(2):189290. https:\/\/doi.org\/10.1016\/j.bbcan.2025.189290","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"6","key":"5569_CR3","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3322\/caac.70018","volume":"75","author":"D Moris","year":"2025","unstructured":"Moris D, Martinino A, Schiltz S, Allen PJ, Barbas A, Sudan D, King L, Berg C, Kim C, Bashir M, Palta M, Morse MA, Lidsky ME (2025) Advances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians. CA Cancer J Clin 75(6):498\u2013527. https:\/\/doi.org\/10.3322\/caac.70018","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"5569_CR4","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1053\/j.gastro.2025.03.047","volume":"169","author":"AG Singal","year":"2025","unstructured":"Singal AG, Salem R, Pinato DJ, Pillai A (2025) Advances in Locoregional and Systemic Treatments for Hepatocellular Carcinoma. Gastroenterology 169(4):585\u2013599. https:\/\/doi.org\/10.1053\/j.gastro.2025.03.047","journal-title":"Gastroenterology"},{"issue":"8","key":"5569_CR5","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3748\/wjg.v29.i8.1243","volume":"29","author":"R Nevola","year":"2023","unstructured":"Nevola R, Ruocco R, Criscuolo L, Villani A, Alfano M, Beccia D, Imbriani S, Claar E, Cozzolino D, Sasso FC, Marrone A, Adinolfi LE, Rinaldi L (2023) Predictors of early and late hepatocellular carcinoma recurrence. World J Gastroenterol 29(8):1243\u20131260. https:\/\/doi.org\/10.3748\/wjg.v29.i8.1243","journal-title":"World J Gastroenterol"},{"issue":"12","key":"5569_CR6","doi-asserted-by":"publisher","first-page":"101571","DOI":"10.1016\/j.jhepr.2025.101571","volume":"7","author":"E Mauro","year":"2025","unstructured":"Mauro E, de Castro T, Zeitlhoefler M, Sung MW, Villanueva A, Mazzaferro V, Llovet JM (2025) Hepatocellular carcinoma: Epidemiology, diagnosis and treatment. JHEP Rep 7(12):101571. https:\/\/doi.org\/10.1016\/j.jhepr.2025.101571","journal-title":"JHEP Rep"},{"key":"5569_CR7","doi-asserted-by":"publisher","first-page":"102403","DOI":"10.1016\/j.bbrep.2025.102403","volume":"45","author":"J Das","year":"2026","unstructured":"Das J, Barman B, Sarma P, Das BK, Chetia R, Kalita PP (2026) Signalling pathways in hepatocellular carcinoma (HCC) metastasis and invasion: Molecular mechanisms and therapeutic implications. Biochem Biophys Rep 45:102403. https:\/\/doi.org\/10.1016\/j.bbrep.2025.102403","journal-title":"Biochem Biophys Rep"},{"key":"5569_CR8","doi-asserted-by":"publisher","first-page":"217846","DOI":"10.1016\/j.canlet.2025.217846","volume":"627","author":"Z Xiang","year":"2025","unstructured":"Xiang Z, Li J, Xu Y, Xu C, Zheng S, Chen J, Wei X, Xu X (2025) Cell differentiation-related signaling pathways in hepatocellular carcinoma metastasis. Cancer Lett 627:217846. https:\/\/doi.org\/10.1016\/j.canlet.2025.217846","journal-title":"Cancer Lett"},{"issue":"3","key":"5569_CR9","doi-asserted-by":"publisher","first-page":"e261","DOI":"10.1002\/mco2.261","volume":"4","author":"Q Zhong","year":"2023","unstructured":"Zhong Q, Xiao X, Qiu Y, Xu Z, Chen C, Chong B, Zhao X, Hai S, Li S, An Z, Dai L (2023) Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications. MedComm (2020) 4(3):e261. https:\/\/doi.org\/10.1002\/mco2.261","journal-title":"MedComm (2020)"},{"key":"5569_CR10","doi-asserted-by":"publisher","first-page":"1667200","DOI":"10.3389\/fonc.2025.1667200","volume":"15","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Song X, Luo W, Xie F, Shen J, He J, Han Z, Huang J (2025) Post-translational modifications of protein and lung cancer. Front Oncol 15:1667200. https:\/\/doi.org\/10.3389\/fonc.2025.1667200","journal-title":"Front Oncol"},{"issue":"Pt 9","key":"5569_CR11","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1107\/s2059798324007794","volume":"80","author":"LC Schofield","year":"2024","unstructured":"Schofield LC, Dialpuri JS, Murshudov GN, Agirre J (2024) Post-translational modifications in the Protein Data Bank. Acta Crystallogr D Struct Biol 80(Pt 9):647\u2013660. https:\/\/doi.org\/10.1107\/s2059798324007794","journal-title":"Acta Crystallogr D Struct Biol"},{"issue":"7","key":"5569_CR12","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nrm3383","volume":"13","author":"KW Moremen","year":"2012","unstructured":"Moremen KW, Tiemeyer M, Nairn AV (2012) Vertebrate protein glycosylation: diversity, synthesis and function. Nat Rev Mol Cell Biol 13(7):448\u2013462. https:\/\/doi.org\/10.1038\/nrm3383","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"5569_CR13","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41580-020-00294-x","volume":"21","author":"KT Schjoldager","year":"2020","unstructured":"Schjoldager KT, Narimatsu Y, Joshi HJ, Clausen H (2020) Global view of human protein glycosylation pathways and functions. Nat Rev Mol Cell Biol 21(12):729\u2013749. https:\/\/doi.org\/10.1038\/s41580-020-00294-x","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"5569_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/glycob\/cww086","volume":"27","author":"A Varki","year":"2017","unstructured":"Varki A (2017) Biological roles of glycans. Glycobiology 27(1):3\u201349. https:\/\/doi.org\/10.1093\/glycob\/cww086","journal-title":"Glycobiology"},{"issue":"14","key":"5569_CR15","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/s41388-023-02622-9","volume":"42","author":"J Fang","year":"2023","unstructured":"Fang J, Zhang Y, Huang C, Lu R, Yu J, Chen R, Wang Y, Zhao X, Yu J, Huang J (2023) Glucose-mediated N-glycosylation of RPTP\u03b1 affects its subcellular localization and Src activation. Oncogene 42(14):1058\u20131071. https:\/\/doi.org\/10.1038\/s41388-023-02622-9","journal-title":"Oncogene"},{"issue":"10","key":"5569_CR16","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1038\/s41556-024-01500-0","volume":"26","author":"C de Caestecker","year":"2024","unstructured":"de Caestecker C, Macara IG (2024) A size filter at the Golgi regulates apical membrane protein sorting. Nat Cell Biol 26(10):1678\u20131690. https:\/\/doi.org\/10.1038\/s41556-024-01500-0","journal-title":"Nat Cell Biol"},{"issue":"12","key":"5569_CR17","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nchembio.2194","volume":"12","author":"C Lopez-Sambrooks","year":"2016","unstructured":"Lopez-Sambrooks C, Shrimal S, Khodier C, Flaherty DP, Rinis N, Charest JC, Gao N, Zhao P, Wells L, Lewis TA, Lehrman MA, Gilmore R, Golden JE, Contessa JN (2016) Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells. Nat Chem Biol 12(12):1023\u20131030. https:\/\/doi.org\/10.1038\/nchembio.2194","journal-title":"Nat Chem Biol"},{"issue":"9","key":"5569_CR18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc3982","volume":"15","author":"SS Pinho","year":"2015","unstructured":"Pinho SS, Reis CA (2015) Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer 15(9):540\u2013555. https:\/\/doi.org\/10.1038\/nrc3982","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"5569_CR19","doi-asserted-by":"publisher","first-page":"e2411740","DOI":"10.1002\/advs.202411740","volume":"12","author":"N Xiong","year":"2025","unstructured":"Xiong N, Du Y, Huang C, Yan Q, Zhao L, Yang C, Sun Q, Gao Z, Wang C, Zhan J, Zhang H, Wang S, Ye Y, Li Y, Shen Z (2025) N-glycosylation Modification of CTSD Affects Liver Metastases in Colorectal Cancer. Adv Sci (Weinh) 12(7):e2411740. https:\/\/doi.org\/10.1002\/advs.202411740","journal-title":"Adv Sci (Weinh)"},{"key":"5569_CR20","doi-asserted-by":"publisher","first-page":"112013","DOI":"10.1016\/j.cellsig.2025.112013","volume":"135","author":"X Liu","year":"2025","unstructured":"Liu X, Ji D, Wen Z, Tang Q, Chen Y (2025) N-glycosylation stabilized TNFAIP6 promotes ovarian cancer metastasis by activating the PI3K-AKT signaling pathway. Cell Signal 135:112013. https:\/\/doi.org\/10.1016\/j.cellsig.2025.112013","journal-title":"Cell Signal"},{"issue":"1","key":"5569_CR21","doi-asserted-by":"publisher","first-page":"10064","DOI":"10.1038\/s41467-025-65078-3","volume":"16","author":"J Gao","year":"2025","unstructured":"Gao J, Sherpa D, Kupko N, Chino H, Zeng J, Shao S (2025) Structures of human organellar SPFH protein complexes. Nat Commun 16(1):10064. https:\/\/doi.org\/10.1038\/s41467-025-65078-3","journal-title":"Nat Commun"},{"key":"5569_CR22","doi-asserted-by":"publisher","unstructured":"Manganelli V, Longo A, Mattei V, Recalchi S, Riitano G, Caissutti D, Capozzi A, Sorice M, Misasi R, Garofalo T (2021) Role of ERLINs in the Control of Cell Fate through Lipid Rafts. Cells 10(9). https:\/\/doi.org\/10.3390\/cells10092408","DOI":"10.3390\/cells10092408"},{"key":"5569_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2026.03.001","author":"L Yan","year":"2026","unstructured":"Yan L, Xu Z, Yao Y, Awang T, Wang X, Wang Y, Ma C, Li N, Song C, Chen XW, Gao N (2026) The Erlin1\/2 complex is a dynamic scaffold for membrane microdomain assembly on the endoplasmic reticulum. Mol Cell. https:\/\/doi.org\/10.1016\/j.molcel.2026.03.001","journal-title":"Mol Cell"},{"issue":"16","key":"5569_CR24","doi-asserted-by":"publisher","first-page":"10433","DOI":"10.1074\/jbc.M809801200","volume":"284","author":"MM Pearce","year":"2009","unstructured":"Pearce MM, Wormer DB, Wilkens S, Wojcikiewicz RJ (2009) An endoplasmic reticulum (ER) membrane complex composed of SPFH1 and SPFH2 mediates the ER-associated degradation of inositol 1,4,5-trisphosphate receptors. J Biol Chem 284(16):10433\u201310445. https:\/\/doi.org\/10.1074\/jbc.M809801200","journal-title":"J Biol Chem"},{"issue":"33","key":"5569_CR25","doi-asserted-by":"publisher","first-page":"5235","DOI":"10.1038\/sj.onc.1208741","volume":"24","author":"MJ Garcia","year":"2005","unstructured":"Garcia MJ, Pole JC, Chin SF, Teschendorff A, Naderi A, Ozdag H, Vias M, Kranjac T, Subkhankulova T, Paish C, Ellis I, Brenton JD, Edwards PA, Caldas C (2005) A 1\u00a0Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes. Oncogene 24(33):5235\u20135245. https:\/\/doi.org\/10.1038\/sj.onc.1208741","journal-title":"Oncogene"},{"issue":"12","key":"5569_CR26","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1158\/1541-7786.Mcr-05-0128","volume":"3","author":"V Gelsi-Boyer","year":"2005","unstructured":"Gelsi-Boyer V, Orsetti B, Cervera N, Finetti P, Sircoulomb F, Roug\u00e9 C, Lasorsa L, Letessier A, Ginestier C, Monville F, Esteyri\u00e8s S, Ad\u00e9la\u00efde J, Esterni B, Henry C, Ethier SP, Bibeau F, Mozziconacci MJ, Charafe-Jauffret E, Jacquemier J, Bertucci F, Birnbaum D, Theillet C, Chaffanet M (2005) Comprehensive profiling of 8p11-12 amplification in breast cancer. Mol Cancer Res 3(12):655\u2013667. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-05-0128","journal-title":"Mol Cancer Res"},{"issue":"12","key":"5569_CR27","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1093\/carcin\/bgad070","volume":"44","author":"B Xiao","year":"2023","unstructured":"Xiao B, Xiang Q, Deng Z, Chen D, Wu S, Zhang Y, Liang Y, Wei S, Luo G, Li L (2023) KCNN1 promotes proliferation and metastasis of breast cancer via ERLIN2-mediated stabilization and K63-dependent ubiquitination of Cyclin B1. Carcinogenesis 44(12):809\u2013823. https:\/\/doi.org\/10.1093\/carcin\/bgad070","journal-title":"Carcinogenesis"},{"key":"5569_CR28","doi-asserted-by":"publisher","first-page":"568440","DOI":"10.3389\/fimmu.2020.568440","volume":"11","author":"Y Liu","year":"2020","unstructured":"Liu Y, Xie P, Jiang D, Liu J, Zhang J, Bian T, Shi J (2020) Molecular and Immune Characteristics for Lung Adenocarcinoma Patients With ERLIN2 Overexpression. Front Immunol 11:568440. https:\/\/doi.org\/10.3389\/fimmu.2020.568440","journal-title":"Front Immunol"},{"issue":"10","key":"5569_CR29","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1093\/hmg\/ddr070","volume":"20","author":"Y Y\u0131ld\u0131r\u0131m","year":"2011","unstructured":"Y\u0131ld\u0131r\u0131m Y, Orhan EK, Iseri SA, Serdaroglu-Oflazer P, Kara B, Solako\u011flu S, Tolun A (2011) A frameshift mutation of ERLIN2 in recessive intellectual disability, motor dysfunction and multiple joint contractures. Hum Mol Genet 20(10):1886\u20131892. https:\/\/doi.org\/10.1093\/hmg\/ddr070","journal-title":"Hum Mol Genet"},{"issue":"3","key":"5569_CR30","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1083\/jcb.201305076","volume":"203","author":"MD Huber","year":"2013","unstructured":"Huber MD, Vesely PW, Datta K, Gerace L (2013) Erlins restrict SREBP activation in the ER and regulate cellular cholesterol homeostasis. J Cell Biol 203(3):427\u2013436. https:\/\/doi.org\/10.1083\/jcb.201305076","journal-title":"J Cell Biol"},{"issue":"22","key":"5569_CR31","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1016\/j.devcel.2023.08.013","volume":"58","author":"QW Teo","year":"2023","unstructured":"Teo QW, Wong HH, Heunis T, Stancheva V, Hachim A, Lv H, Siu L, Ho J, Lan Y, Mok CKP, Ulferts R, Sanyal S (2023) Usp25-Erlin1\/2 activity limits cholesterol flux to restrict virus infection. Dev Cell 58(22):2495\u20132509. https:\/\/doi.org\/10.1016\/j.devcel.2023.08.013","journal-title":"Dev Cell"},{"issue":"28","key":"5569_CR32","doi-asserted-by":"publisher","first-page":"20104","DOI":"10.1074\/jbc.M701862200","volume":"282","author":"MM Pearce","year":"2007","unstructured":"Pearce MM, Wang Y, Kelley GG, Wojcikiewicz RJ (2007) SPFH2 mediates the endoplasmic reticulum-associated degradation of inositol 1,4,5-trisphosphate receptors and other substrates in mammalian cells. J Biol Chem 282(28):20104\u201320115. https:\/\/doi.org\/10.1074\/jbc.M701862200","journal-title":"J Biol Chem"},{"issue":"1","key":"5569_CR33","doi-asserted-by":"publisher","first-page":"16226","DOI":"10.1038\/s41598-023-42801-y","volume":"13","author":"P Dai","year":"2023","unstructured":"Dai P, Xiong L, Wei Y, Wei X, Zhou X, Zhao J, Tang H (2023) A pancancer analysis of the oncogenic role of cyclin B1 (CCNB1) in human tumors. Sci Rep 13(1):16226. https:\/\/doi.org\/10.1038\/s41598-023-42801-y","journal-title":"Sci Rep"},{"issue":"5","key":"5569_CR34","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1177\/15353702211049149","volume":"247","author":"MH Rong","year":"2022","unstructured":"Rong MH, Li JD, Zhong LY, Huang YZ, Chen J, Xie LY, Qin RX, He XL, Zhu ZH, Huang SN, Zhou XG (2022) CCNB1 promotes the development of hepatocellular carcinoma by mediating DNA replication in the cell cycle. Exp Biol Med (Maywood) 247(5):395\u2013408. https:\/\/doi.org\/10.1177\/15353702211049149","journal-title":"Exp Biol Med (Maywood)"},{"issue":"3","key":"5569_CR35","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1042\/bj20112050","volume":"446","author":"G Wang","year":"2012","unstructured":"Wang G, Zhang X, Lee JS, Wang X, Yang ZQ, Zhang K (2012) Endoplasmic reticulum factor ERLIN2 regulates cytosolic lipid content in cancer cells. Biochem J 446(3):415\u2013425. https:\/\/doi.org\/10.1042\/bj20112050","journal-title":"Biochem J"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05569-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05569-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05569-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T08:24:24Z","timestamp":1784276664000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05569-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["5569"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05569-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8602481\/v1","asserted-by":"object"}]},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental animal protocols received formal approval from the Experimental Animal Ethics Committee of Guizhou Medical University.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have reviewed and consented to the final published version of this manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}